Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Memphasys Ltd ( (AU:MEM) ) has provided an announcement.
Memphasys Ltd has announced the quotation of 180,460,810 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of November 10, 2025. This move is part of a previously announced transaction and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the company’s financial flexibility and visibility in the market.
More about Memphasys Ltd
Memphasys Ltd operates in the biotechnology sector, focusing on reproductive biotechnology products and services. The company is known for its innovative solutions aimed at improving fertility treatments and reproductive health.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$10.46M
Learn more about MEM stock on TipRanks’ Stock Analysis page.